CluePoints Co-Founder And Chief Executive Officer To Speak At SCOPE Europe

Francois Torche, Co-Founder and Chief Executive Officer at CluePoints, will share insights into utilizing Risk-Based Quality Management (RBQM) to improve trial outcomes at this year’s SCOPE Europe, the 4th annual Summit for Clinical Trials Operations Executives.

Harnessing Risk-Based Quality Management and Deep Learning to Improve Trial Knowledge and Drive Better Decision-Making and Outcomes will occur at 3:55 pm on Wednesday, April 20.

During this session, Francois will explain the evolution of risk-based techniques over the past ten years and novel analytical techniques’ increasing role in supporting a risk-based approach.  In addition, he will explore the role of deep learning and machine learning in delivering better insights to enable data managers and study team members to make better and more targeted decisions.

Francois Torche, Co-Founder and CEO, CluePoints

François holds a master’s in business administration from the ICHEC School of Management in Brussels. He spent more than two decades working in the pharmaceutical industry as a statistical programmer, SAS and JAVA developer, and IT project leader for companies such as GSK, UCB, and IDDI before helping to develop the CluePoints SMART™ engine. This patent-pending software solution underpins CluePoints’ pioneering work.

Francois has served as CluePoints’ Chief Executive Officer since the company’s inception in 2012.


CluePoints is a central statistical monitoring solution that employs unique statistical algorithms to determine clinical trial data quality, accuracy, and integrity, both during and after study conduct.

Aligned with guidance from the FDA and EMA, CluePoints is deployed to support traditional on-site monitoring and can be implemented as the engine to drive a risk-based monitoring strategy.

SCOPE Europe

SCOPE Europe is a two-day hybrid event in Barcelona, Spain, on April 20 – 21, 2022. It brings together clinical innovation leaders, digital leaders, functional heads, and those responsible for planning and managing clinical trials in Europe and globally.

This year’s theme is the Decentralization and Digitalization of Clinical Trials. The two-day event features four conference tracks, shared plenary keynotes, interactive breakout discussion groups, panels, and networking.

Discover more and book your pass at

The Bold Future of RBQM for CROs
Meet SPOT: Transforming Site Monitoring Practices with Adaptive Intelligence
A New Era of Automation: Improving Efficiency & Outcomes with Intelligent Medical Coding